Where To Start Tackling ‘Long Covid’? PureTech Pioneers Lung Drug Trial

Phase II Readout Expected Later This Year

 
• By Andrew McConaghie

PureTech is among the very first companies to attempt to treat long Covid and hopes its anti-fibrosis drug can aid patients’ recovery

Covid rehab
Even after recovery from COVID-19, many patients are left with long-term health problems, including breathlessness and fatigue. • Source: Getty Images

More from Business

More from Scrip